Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery Torsten Doenst, MD, PhD,

Slides:

Advertisements

Similar presentations

Manuel J. Antunes, MD, PhD, DSc

Advertisements

David W. Barbara, MD, William J. Mauermann, MD, James R

“Lead from the front”: Participative leadership

Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery Kazuto Yokoyama,

Amine Mazine, MD, MSc, Subodh Verma, MD, PhD, Bobby Yanagawa, MD, PhD

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Sequela-free long-term survival of a 65-year-old woman after 8 hours and 40 minutes of cardiac arrest from deep accidental hypothermia Marie Meyer, MD,

The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Go on-pump or off-pump in diabetic patients?

The use of vancomycin paste to reduce sternal wound infections after cardiac surgery— why is this still a “sticky” subject Harold L. Lazar, MD The Journal.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

Igor E. Konstantinov, MD, PhD, FRACS

Michael A. Borger, MD, PhD, Patricia M

Conduit conundrum: If not two, why three?

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC

Cost, quality, and value in coronary artery bypass grafting

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Torsten Doenst, MD, PhD, Markus Richter, MD

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

A derived and validated score to predict prolonged mechanical ventilation in patients undergoing cardiac surgery Vivek Sharma, MD, FRCA, Vivek Rao, MD,

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Christopher M. Feindel, MD, MSc, Maral Ouzounian, MD, PhD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

The diabetes epidemic and its effect on cardiac surgery practice

Niv Ad, MD, Lawrence M. Wei, MD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor Verdi J. DiSesa, MD, MBA The Journal of.

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

The harder one looks, the more one finds

The impact of frailty on postoperative delirium in cardiac surgery patients Patrick Jung, BSc, Michael Ashley Pereira, BSc, Brett Hiebert, MSc, Xiaiwei.

Innovation in cardiothoracic surgical training

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting Castigliano M. Bhamidipati,

Between a rock and a hard place

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

Repetition is the mother of skill

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

The evolution of cardiothoracic critical care

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Presentation transcript:

Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery Torsten Doenst, MD, PhD, Duminda Wijeysundera, MD, Keyvan Karkouti, MD, Christoph Zechner, MD, Manjula Maganti, MSc, Vivek Rao, MD, PhD, Michael A. Borger, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 130, Issue 4, Pages 1144.e1-1144.e8 (October 2005) DOI: 10.1016/j.jtcvs.2005.05.049 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Peak glucose levels during cardiopulmonary bypass (CPB) and operative mortality in diabetic (n = 1579) and nondiabetic (n = 4701) patients operated on at our institution between January 1999 and December 2001. The numbers at the top of the columns indicate the percentage of patients with peak glucose levels in the respective range. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1144.e1-1144.e8DOI: (10.1016/j.jtcvs.2005.05.049) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Highest serum glucose level during cardiopulmonary bypass (CPB) as a function of the duration of cardiopulmonary bypass in nondiabetic patients (n = 6280; Spearman correlation coefficient, r = 0.43). Note that 25 mmol/L (450 mg/dL) is the highest value the glucose analyzer displays. Thus a value of 25 mmol/L might reflect an even higher glucose level. The Journal of Thoracic and Cardiovascular Surgery 2005 130, 1144.e1-1144.e8DOI: (10.1016/j.jtcvs.2005.05.049) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions